Steven J Greco

Steven J. Greco, PhD, is a highly respected figure in regenerative medicine from Pinehurst, TX. As the Founder and Chief Operating Officer of PranaX Corporation, a biomedical research company based in Houston, he has made notable contributions to the understanding and application of regenerative therapies. Greco's academic background includes a degree in Biological Sciences from Cornell University, followed by a PhD in Stem Cell Biology from Rutgers University, where he specialized in biomedical sciences. His research utilizes exosome biology to foster regenerative processes, specifically repairing tissues and organs damaged by age-related conditions. Greco’s expertise in regenerative medicine is built on years of scientific study and hands-on experience with various biotech companies. His work with early-stage biotech ventures allowed him to develop a deep understanding of drug development processes, which ultimately led him to co-found Rejenevie Therapeutics and serve as Chief Scientific Officer at Houston Healthspan Innovation Group, both of which were eventually acquired as subsidiaries of PranaX, the company he founded in 2022. PranaX became a platform for Greco to apply his academic research on Alzheimer’s disease and other aging-related conditions, focusing on in vitro diagnostics and biomarker identification as part of their innovative medical solutions. Steven J. Greco has been at the forefront of stem cell research for over two decades, with a particular focus on regenerative and translational medicine. His passion for rejuvenation medicine extends beyond research; he is also dedicated to education and outreach. As the founder of the Stem Cell Education Society, Greco has worked tirelessly to raise public awareness of stem cell therapies and their potential to improve health outcomes. He actively participates in educating students, scientists, and professionals on the latest developments in the field, helping shape the next generation of researchers.